[Streptococcus agalactiae isolated in Santa Fe, Argentina: antibiotic susceptibility and erythromycin-clindamycin resistance mechanisms].
Mollerach
Analía
A
Méndez
Emilce
E
Massa
Rosana
R
Di Conza
José
J
D000667:Ampicillin / Q000494:pharmacology; D001118:Argentina / Q000453:epidemiology; D001426:Bacterial Proteins / Q000235:genetics / Q000502:physiology; D002981:Clindamycin / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D004917:Erythromycin / Q000494:pharmacology*; D005798:Genes, Bacterial; D006801:Humans; D008780:Methyltransferases / Q000235:genetics / Q000502:physiology; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D013290:Streptococcal Infections / Q000453:epidemiology / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification*
D001426:Bacterial Proteins; D010406:Penicillins; D002981:Clindamycin; D004917:Erythromycin; D000667:Ampicillin; D015242:Ofloxacin; C111078:ErmTR protein, bacteria; D008780:Methyltransferases